News Related to Evotec SE

Related coverage linked through entity extraction aliases.

Evotec Gets $10 Million Milestone as BMS Starts Phase 1 Trial of BMS-986506

Apr 13, 2026

Bristol Myers Squibb started a Phase 1 trial of BMS-986506 in clear cell renal cell carcinoma, triggering a $10 million milestone payment to Evotec SE. The candidate is the first molecular glue from the companies’ protein-degradation partnership to enter human testing.

Drug Discovery Services Market Projected to Reach $75.13 Billion by 2034

Mar 02, 2026

The global drug discovery services market is valued at $22.04 billion in 2025 and is forecast to reach $75.13 billion by 2034, growing at a 14.6% CAGR from 2026-2034, driven by rising industry demand and technological advancements.